TECAN US LAUNCHES FREEDOM EVOWARE® SOFTWARE AT LAB AUTOMATION 2004
Research Triangle Park, NC and San Jose, CA February 2, 2004 – Tecan US, a leader in the Life Sciences supply industry, today introduced Freedom EVOware,® a unique pipetting and instrument control software package with dynamic scheduling for Tecan’s Freedom EVO series of liquid handling workstations. This flexible software package simplifies the control of Freedom EVO with its intuitive graphical interface that makes it easy-to-use by all levels of laboratory personnel. In addition, Freedom EVOware® provides support for compliance with 21 CFR part 11 regulatory requirements.
According to Carl Severinghaus, President, Tecan US, “We are proud to introduce our state-of-the-art robotic software, Freedom EVOware® at Lab Automation 2004.” Severinghaus further adds, “This novel software package combined with our Freedom EVO series of liquid handling platforms opens the door to a powerful software and hardware solution for a wide range of users in the Life Sciences industry.”
The EVOware® software package guides the user through the program and can manage the simplest to the most complex scheduling and operative tasks. Drag-and- drop moves simplify worktable definition, and application templates speed the creation of protocols. 3D simulation saves valuable time by enabling the user to preview the process before running it on the Freedom EVO. In addition, Freedom EVOware® offers system integrators an extensive library of over 75 drivers for detection, separation, robotics and plate handling and storage devices from Tecan and 3rd party vendors. System customization is supported through a variety of open interfaces for device drivers, automation, work listing and messaging, providing flexibility for all levels of users.
About Tecan
Tecan (www.tecan.com) is a leading player in the Life Sciences supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2002, Tecan achieved sales of CH 332.2 million (USD 212.9 million; EUR 226.0 million). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor : 1210019).
CONTACT:
Michele Valenta, Marketing Communications Manager, Tecan US, 919.361.5200, or Lisa Wilder, President, Wilder Communications, Inc., 919.349.3357
